Foreign Subsidiary Earnings Bill Headed For Senate Floor? Med Tech On Board
This article was originally published in The Gray Sheet
Executive Summary
Senate legislation granting firms a one-time tax break on repatriation of overseas income could go to the floor before November adjournment, according to staffers
You may also be interested in...
Repatriation Tax Bill Eyed By Device Firms As Opportunity For R&D Windfall
Boston Scientific is rallying the medical technology sector to support legislation (HR 767, S 596) that would lift tax restrictions on repatriation of foreign profits by U.S. firms
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.